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Abstract
Background: Although increased capillary permeability is the major clinical feature associated with severe dengue
infections the mechanisms underlying this phenomenon remain unclear. Dextran clearance methodology has been used to
investigate the molecular sieving properties of the microvasculature in clinical situations associated with altered
permeability, including during pregnancy and in various renal disorders. In order to better understand the characteristics of
the vascular leak associated with dengue we undertook formal dextran clearance studies in Vietnamese dengue patients
and healthy volunteers.
Methodology/Principal Findings: We carried out serial clearance studies in 15 young adult males with acute dengue and
evidence of vascular leakage a) during the phase of maximal leakage and b) one and three months later, as well as in 16
healthy control subjects. Interestingly we found no difference in the clearance profiles of neutral dextran solutions among
the dengue patients at any time-point or in comparison to the healthy volunteers.
Conclusions/Significance: The surface glycocalyx layer, a fibre-matrix of proteoglycans, glycosaminoglycans, and plasma
proteins, forms a complex with the underlying endothelial cells to regulate plasma volume within circumscribed limits. It is
likely that during dengue infections loss of plasma proteins from this layer alters the permeability characteristics of the
complex; physical and/or electrostatic interactions between the dextran molecules and the glycocalyx structure may
temporarily restore normal function, rendering the technique unsuitable for assessing permeability in these patients. The
implications for resuscitation of patients with dengue shock syndrome (DSS) are potentially important. It is possible that
continuous low-dose infusions of dextran may help to stabilize the permeability barrier in patients with profound or
refractory shock, reducing the need for repeated boluses, limiting the total colloid volume required. Formal clinical studies
should help to assess this strategy as an alternative to conventional fluid resuscitation for severe DSS.
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Introduction
Dengue infection is increasingly being recognised as a major
burden on global health [1]. Infection with any of the four viral
serotypes may result in asymptomatic infection, or cause a variety
of disease manifestations ranging from non-specific fever to a
severe syndrome characterised by increased vascular permeability,
deranged haemostasis and thrombocytopenia [2]. Considerable
volumes of plasma can be lost from the intravascular compartment
resulting in potentially fatal dengue shock syndrome. Despite the
fact that vascular leakage is the pathognomonic feature of severe
dengue, little is known of the mechanisms underlying the change
in permeability. The prevailing view is that dengue infection
triggers an immunopathogenic cascade that alters microvascular
structure or function in some as yet undefined way, resulting in a
transient, spontaneously-reversible increase in permeability [3].
Plasma volume is normally regulated within tightly circum-
scribed limits by complex homeostatic mechanisms, with plasma
and interstitial fluid existing in dynamic equilibrium separated by
the semi-permeable capillary wall [4,5]. The surface glycocalyx
layer, a highly anionic fibre-matrix of proteoglycans, glycosami-
noglycans, and plasma proteins anchored in the plasma mem-
brane of endothelial cells, is considered to be the primary barrier,
functioning as a molecular sieve to selectively restrict molecules
within the plasma and limit access to the endothelial cell layer
which forms the secondary barrier. In general, small molecules are
freely filtered, permeability decreases as molecular size increases,
and large or negatively charged molecules are relatively protected
within the circulation.
Although the basic mechanisms governing filtration at the
glomerulus are intrinsically similar to those operating in the rest of
the microvascular circulation, additional highly specialised mech-
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of a glomerular filtration rate of the order of 180 litres/day in
adults, resulting in production of virtually protein free urine in
normal circumstances [5,6]. Increases in glomerular protein
permeability demonstrated in patients without renal disease are
likely to indicate substantial increases in systemic vascular
permeability. Recent research in various diseases with altered
capillary permeability such as diabetes and coronary atheroscle-
rosis indicates a range of pathological effects on the surface
glycocalyx layer of the systemic microvasculature, with early
microalbuminuria thought to reflect these systemic changes rather
than being directly of renal origin [7–10].
Knowledge of the sieving properties of capillary beds can be
obtained by measuring the fractional clearance of test macromol-
ecules [11,12]. The clearance of a molecule is equal to the excretion
in urine per unit time divided by the concentration in plasma,
provided no modification occurs in the kidneys. Relating this
clearance to that of a freely filtered reference marker that is neither
secreted nor absorbed adjusts for the glomerular filtration rate.
Since many endogenous proteins are secreted and/or absorbed in
the renal tubules, fractional clearance measurements of non-
reabsorbable synthetic polymers such as dextrans are preferred.
Both hypoalbuminaemia and proteinuria are seen during
dengue infections, without evidence of renal impairment. Marked
increases in fractional clearances of several endogenous proteins,
notably albumin, have been documented during the critical phase
for leakage [13]. In order to better understand the characteristics
of the vascular leak associated with dengue, we undertook formal
dextran clearance studies in a group of Vietnamese patients with
dengue and a similar group of healthy volunteers as controls.
Methods
Clinical Methods
Serial dextran clearance studies were carried out on adult male
patients at the Hospital for Tropical Diseases (HTD) of Ho Chi
Minh City, all with dengue and evidence of vascular leakage, a)
during the phase of maximal leakage and b) one and three months
later. Similar clearance studies were performed on healthy male
volunteers with no history of febrile illness for 3 months. All
subjects gave written informed consent, and approval was
obtained from HTD and the Oxford Tropical Research Ethics
Committee. All studies took place in a dedicated pharmacology
research room on a high-dependency ward supervised by an
experienced clinician.
Following established methodology, a 50 ml bolus of 10%
Dextran 40 in normal saline (Rheopolyglukin, Kraspharma,
Russia) plus 5% inulin (InutestH 25%, Fresenius Kabi, Austria)
was administered over 10 minutes to supine resting subjects,
followed by a maintenance infusion of the same solution at 1 ml/
min for 2 hours [12]. Inulin is commonly used as the standard for
measuring ultrafiltration of small solutes. Blood samples (2 mL)
were collected from the contralateral arm at baseline, and again
after 70 and 130 minutes, to coincide with the mid-point of timed
urine collections performed between 60–80 and 120–140 minutes
immediately after the subject had voided the bladder. Subjects
were encouraged to drink plenty of water and vital signs were
recorded before and every 30 minutes during the test. The exact
timings of fluid administration and sample collection were
carefully recorded. Samples were immediately separated and
stored at 220uC until analysed subsequently in batches.
Sample analysis
All samples from one subject were analysed on the same day by
high performance liquid chromatography (HPLC) using a
LaChrom Elite system (Merck, Germany) including one auto-
sampler with cooling unit (L-2200), two high throughput analysis
pumps (model L-2130), a column oven (model L-2350) and a
Diode Array Detector (model L-2455). All plasma and urine
samples were first deproteinized with 20% trichloroacetic acid.
Dextrans. Polydisperse dextrans were separated into narrow
fractions according to their molecular size by HPLC, with two
columns Ultrahydrogel 500 and 250 in series protected by a guard
column (Waters Corp., USA) [11], infusing a 0.02 M phosphate
buffer (pH 7). Chromatography was carried out at 35uC, with a
flow rate at 0.5 mL/min and UV detection at 625 nm. Multiple
eluting fractions (250 mL) were collected between 25–45 minutes,
and the dextran concentrations were estimated by colorimetry
using anthrone assays [14]. The columns were calibrated using 6
standard dextrans ranging from 5–500 kD (Pharmacosmos,
Denmark), and the void volume (V0) was determined with Blue
Dextran (Sigma, USA).
Inulin. After pre-treatment with perchloric acid, inulin
concentrations were measured by HPLC using a LichroCart
RP-18 column and its corresponding guard column (Merck,
Germany) and a 0.01 M phosphate buffer in 4% acetonitrile [15].
Chromatography was carried out on 20 mL of each sample over
8 minutes at 1 mL/min, giving an inulin peak retention time at
5.21 minutes (l=285 nm). Precision and accuracy were
acceptable with a coefficient of variability ,15%.
Fractional clearance calculations
Fractional clearances of dextran were calculated as follows:
hDex=(U/P)Dex/(U/P)Inu, which refer to the urine-to-midpoint
plasma concentration ratios of dextran and inulin respectively.
The fractional volume was determined as Kav=(V e2V0)/
(Vt2V0), where Ve is the elution volume of each dextran in
individual fractions and Vt is the total volume of the column,
estimated with glucose. The molecular radius was calculated by
Rst=0.336M
0.463, M being the molecular weight at the peak
Author Summary
Dengue is a potentially serious common viral infection
with no specific treatment. Plasma leakage from small
blood vessels is the major severe problem, but we do not
understand how this occurs. Techniques using controlled
infusions of carbohydrate solutions, combined with careful
measurement of the rate that the different-sized molecules
clear from the circulation, have been successfully used to
investigate leakage in other situations. We performed
carbohydrate clearance studies in 15 Vietnamese adult
males with dengue and plasma leakage, comparing results
obtained during the acute illness with recovery values, and
results from a group of healthy volunteers. However, we
found no differences between any of the clearance profiles
measured. One possible explanation may be that the
carbohydrate molecules interact with blood vessels,
temporarily restoring their normal barrier function. Al-
though this means that the technique is unsuitable for
investigating leakage in dengue patients, the implications
for management of patients with severe leakage resulting
in shock are potentially important. Patients with profound
shock are usually managed with intermittent large boluses
of carbohydrate or similar solutions, sometimes causing
severe side-effects; however if continuous low-dose
infusions actually stabilized the permeability barrier, this
might reduce the need for repeated boluses, thereby
minimizing these adverse effects.
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fractions was estimated by the relationship between Kav and Rst of
the standard dextran solutions.
Results
Between November 2008 and February 2009 15 male patients,
median(range) 25(18–30) years,wererecruited tothe study.Allhad
clinically suspected dengue with evidence of vascular leakage
(progressively rising haematocrit (11/15) and/or pleural effusion or
ascites on ultrasound (5/15) and/or hypoalbuminaemia (9/15)) at
the time of study, but were well-compensated cardiovascularly. One
patient was diagnosed as having vascular leakage on the basis of
development of significant hypoalbuminaemia alone, with the
plasma albumin dropping from 47 g/L to 39.5 g/L on day 4 of
illness. This patient received maintenance parenteral fluid therapy,
likely masking the rise in haematocrit usually seen in association
with such a reduction in plasma albumin. All initial studies took
place between days 4–6 of illness (the first day of illness was defined
as the day of fever onset), with 13/15 on day 5. No patient
developed shock and all recovered fully with conventional
symptomatic care. Throughout the course of the illness 11/15
patients experienced either skin or minor mucosal bleeding and the
median (range) platelet nadir was 25,000 (8,000–111,000) cells/ml.
All patients were subsequently confirmed to have dengue using
standard serological/virological methods (5 patients sero-converted,
while in 10 a virus was identified on RT-PCR, 5 DENV_1, 3
DENV_2 and 2 DENV_3) [16]. Sixteen healthy male students,
median (range) 24 (23–28) years, acted as controls. Clearance
studies were generally well toleratedalthough one patient developed
a minor febrile reaction shortly after the dextran infusion.
Figure 1 depicts the dextran fractional clearance curves for the
acute and convalescent studies performed in the dengue patients,
together with results for the control subjects. All curves represent
the results from the first timed collection. No detectable differences
were apparent between any of the curves. There were no
differences in inulin clearances between the groups during the
acute illness or between acute illness measurements and follow-up
measurements within any of the groups, consistent with the
persistently normal renal function indices observed in all patients
throughout the duration of the study.
Discussion
Fractional clearance methodology is well established for
investigating renal disorders and has provided useful insights into
the pathogenesis of the systemic leak associated with meningococcal
septicaemia and dengue, in both of which considerable increases in
clearancesofendogenousproteinswere observedconsistentwiththe
severity of leakage [13,17]. However, in these formal dextran
clearance studies in dengue patients we found no difference in the
clearance profiles of polydisperse neutral dextran solutions either a)
duringtheperiodofmaximalleakage comparedtotheirownfollow-
up profiles, or b) compared to the profiles observed in a similar
Figure 1. Dextran fractional clearances. Panel A: Mean and standard deviation dextran fractional clearances (hD) for dengue patients during the
acute phase (n=15), and at 1 month (n=15) and 3 months (n=14) following recovery, compared with healthy volunteers (n=16). For reasons of
clarity the standard deviation markers are only presented for the acute dengue results, and for the healthy volunteers. Panels B and C: For
comparison, these panels depict schematic examples of typical patterns seen when clearances are reduced, for example during pregnancy, or
increased, for example in patients with renal disorders.
doi:10.1371/journal.pntd.0001282.g001
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evidence of leakage, none developed DSS and they were thus
comparatively less severe than the patient group we previously
studied, in whom marked increases in protein clearances were
demonstrated in association with DSS. Unfortunately nevertheless
we did not measure clearances of endogenous proteins prior to the
dextran clearance studies so we cannot be sure that they did have
increased protein losses at baseline; however ongoing studies in our
unit indicate that all patients with dengue have some degree of
microalbuminuria and that most patients with demonstrable
vascular leakage have proteinuria on dipstick testing.
One possible explanation for this unexpected finding of normal
dextran clearances during the period of vascular leakage is that a
physical and/orelectrostaticinteractionoccurs betweenthedextran
molecules and the surface glycocalyx/endothelial cell complex,
temporarily improving its permeability characteristics during the
infusion and rendering the technique unsuitable for assessing
permeability in such patients. Both structural and functional
characteristics of the glycocalyx are known to depend in part on
integration of endogenous plasma proteins, especially albumin,
within the layer [4,6]. Although the pathogenesis of dengue
associated vascular leakage remains unknown, significant losses of
albumin and other proteins from the circulating plasma occur, and
some washout of proteins from the glycocalyx layer must follow,
compromising the function of the layer. However, replacement of
lost proteins by synthetic colloid molecules may temporarily restore
the permeability characteristics of the barrier. From animal studies
incorporation of small dextran molecules into the glycocalyx layer is
known to occur almost immediately, while larger molecules usually
remain restricted within the circulating plasma for several hours
[18]. In situations where the protein content of the glycocalyx is
markedly reduced, it is possible that the rate and range of colloid
molecules rapidly entering the layer increases. Colloid infusions
have been shown to restore permeability in a pig heart model of
ischaemia/reperfusion injuries [19,20], and clinical experience
using neutral dextran solutions for resuscitating patients with DSS
indicates that the volume effect of a given bolus considerably
exceeds the actual volume infused, supporting the idea that colloid
molecules transiently restore the permeability barrier thereby
reducing the leakage of proteins temporarily [21].
In recent years there has been increasing interest in investigat-
ing the mechanisms and regulation of glycocalyx synthesis and
turnover, in the hope that such knowledge might lead to the
development of novel therapeutic strategies to reduce patholog-
ically increased permeability [5]. Thus, heparin injections are
known to mitigate the severe protein losing enteropathy that
develops in some children following complex cardiac surgery due
to loss of heparan sulfate proteoglycans from the intestinal
epithelial glycocalyx [22,23]. Use of heparin is limited by adverse
effects, but alternative strategies to restore gut epithelial glycocalyx
function using synthetic heparin-like compounds are being actively
pursued [24]. Similarly, alterations to the glycocalyx layer in the
coronary microcirculation are thought to contribute to myocardial
ischaemia and the subsequent reperfusion injuries that result in
localised vascular leakage; prevention of glycocalyx loss and/or
restoration of damaged glycocalyx are being investigated as
potential interventions to reduce myocardial damage in these
circumstances [20,25,26].
The implications of these findings for resuscitation of patients
with DSS are potentially important. Prompt restoration of
circulating plasma volume is the cornerstone of therapy, and
WHO management guidelines recommend initial resuscitation
with crystalloid solutions followed by boluses of colloids for
patients with recurrent or refractory shock, aiming to achieve
cardiovascular stability with the minimum volume necessary to
maintain vital organ functions until normal permeability is
restored [2,17]. However, patients with severe leakage are
intrinsically difficult to manage and often require multiple boluses
of colloid during this period, putting them at significant risk of
respiratory distress due to fluid overload, and of haemorrhagic
complications due to colloid induced haemostatic dysfunction
compounding the intrinsic coagulopathy and thrombocytopenia
induced by dengue infection. These results indicate that an
alternative resuscitation strategy may be beneficial in some
circumstances – in severe cases continuous low-dose infusions of
dextran may help to stabilise the permeability barrier, reducing
the need for repeated boluses and limiting the total volume of
colloid infused, thereby minimising adverse effects on coagulation
and respiratory function. Further work is needed to confirm these
findings in patients with demonstrably increased fractional protein
clearances and to investigate whether the effect is similar with
other colloid solutions. If the findings are confirmed, formal
randomised and blinded intervention studies should help to
address the question of whether continuous low dose colloid
infusions improve outcome in severe DSS.
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